Agios Pharmaceuticals AGIO Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Agios Pharmaceuticals's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Agios Pharmaceuticals's total current assets?
- Agios Pharmaceuticals (AGIO) reported total current assets of $834.84M in Q1 2026.
- How has Agios Pharmaceuticals's total current assets changed year-over-year?
- Agios Pharmaceuticals's total current assets decreased by 13.8% year-over-year, from $968.62M to $834.84M.
- What is the long-term trend for Agios Pharmaceuticals's total current assets?
- Over 5 years (2020 to 2025), Agios Pharmaceuticals's total current assets has grown at a 8.2% compound annual growth rate (CAGR), from $636.68M to $942.05M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.